ConductScience.org, home

Paper7744265

AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?

Zaretsky MD. Genetica, 1995. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter? Papers, record 7744265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7744265

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?
PubMed
Journal
Genetica
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zaretsky MDM D

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
HIV SeropositivityMajor topic
ZidovudineMajor topic
CD4-Positive T-Lymphocytes
Cohort Studies
Double-Blind Method
Female
Humans
Immune System
Lymphocyte Count
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N0I-AI-82515NIAID NIH HHSUnited StatesN01AI082515PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11969115
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
N Engl J Med1990https://conductscience.org/library/papers/1969115PubMed
23299089The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.N Engl J Med1987https://conductscience.org/library/papers/3299089PubMed
33044087Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection.Am J Med1988https://conductscience.org/library/papers/3044087PubMed
41611806Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine.Clin Pharmacol Ther1992https://conductscience.org/library/papers/1611806PubMed
58100612Zidovudine now or later?N Engl J Med1993https://conductscience.org/library/papers/8100612PubMed
62847772Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives.Br J Haematol1988https://conductscience.org/library/papers/2847772PubMed
72903403Zidovudine and bone marrow.Lancet1988https://conductscience.org/library/papers/2903403PubMed
88096582Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.Lancet1993https://conductscience.org/library/papers/8096582PubMed
92554533A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment.Toxicol Appl Pharmacol1989https://conductscience.org/library/papers/2554533PubMed
108425021Nucleoside analogs: similarities and differences.Clin Infect Dis1993https://conductscience.org/library/papers/8425021PubMed
118100273A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men.J Acquir Immune Defic Syndr (1988)1993https://conductscience.org/library/papers/8100273PubMed
123540327Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study.JAMA1987https://conductscience.org/library/papers/3540327PubMed
138096373CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.Ann Intern Med1993https://conductscience.org/library/papers/8096373PubMed
143497175Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome.J Clin Invest1987https://conductscience.org/library/papers/3497175PubMed
153299090The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.N Engl J Med1987https://conductscience.org/library/papers/3299090PubMed
166465173Hematologic abnormalities in the acquired immune deficiency syndrome.Am J Med1984https://conductscience.org/library/papers/6465173PubMed
177904317Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.JAMA1994https://conductscience.org/library/papers/7904317PubMed
183477107Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).Ann Intern Med1987https://conductscience.org/library/papers/3477107PubMed
192991932High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2991932PubMed
203010072Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.MMWR Morb Mortal Wkly Rep1986https://conductscience.org/library/papers/3010072PubMed

See all 39 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
12183239Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12183239PubMed
10389983Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.Br J Cancer1999https://conductscience.org/library/papers/10389983PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7744265

GET https://conductscience.org/api/papers/v1/7744265/references?page=2